Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Insulitis in the pathogenesis of type 1 diabetes.

Pugliese A.

Pediatr Diabetes. 2016 Jul;17 Suppl 22:31-6. doi: 10.1111/pedi.12388. Review.

PMID:
27411434
2.

Comparison of Metabolic Outcomes in Children Diagnosed with Type 1 Diabetes Through Research Screening (Diabetes Autoimmunity Study in the Young [DAISY]) Versus in the Community.

Chan CL, Taki I, Dong F, Hoffman M, Norris JM, Klingensmith G, Rewers MJ, Steck AK.

Diabetes Technol Ther. 2015 Sep;17(9):649-56. doi: 10.1089/dia.2015.0029. Epub 2015 Jun 3.

3.

Preserved C-peptide levels in overweight or obese compared with underweight children upon diagnosis of type 1 diabetes mellitus.

Yu HW, Lee YJ, Cho WI, Lee YA, Shin CH, Yang SW.

Ann Pediatr Endocrinol Metab. 2015 Jun;20(2):92-7. doi: 10.6065/apem.2015.20.2.92. Epub 2015 Jun 30.

4.

The development of next-generation screening and diagnostic platforms will change diabetes care.

Kumar RB, Gupta M, Feldman BJ.

Expert Rev Mol Diagn. 2015 Mar;15(3):291-4. doi: 10.1586/14737159.2015.1002468. Epub 2015 Jan 13.

5.

The SEARCH for Diabetes in Youth study: rationale, findings, and future directions.

Hamman RF, Bell RA, Dabelea D, D'Agostino RB Jr, Dolan L, Imperatore G, Lawrence JM, Linder B, Marcovina SM, Mayer-Davis EJ, Pihoker C, Rodriguez BL, Saydah S; SEARCH for Diabetes in Youth Study Group..

Diabetes Care. 2014 Dec;37(12):3336-44. doi: 10.2337/dc14-0574. Review.

6.

Correlates of treatment patterns among youth with type 2 diabetes.

Badaru A, Klingensmith GJ, Dabelea D, Mayer-Davis EJ, Dolan L, Lawrence JM, Marcovina S, Beavers D, Rodriguez BL, Imperatore G, Pihoker C.

Diabetes Care. 2014;37(1):64-72. doi: 10.2337/dc13-1124. Epub 2013 Sep 11.

7.

Residual β-Cell function 3-6 years after onset of type 1 diabetes reduces risk of severe hypoglycemia in children and adolescents.

Sørensen JS, Johannesen J, Pociot F, Kristensen K, Thomsen J, Hertel NT, Kjaersgaard P, Brorsson C, Birkebaek NH; Danish Society for Diabetes in Childhood and Adolescence..

Diabetes Care. 2013 Nov;36(11):3454-9. doi: 10.2337/dc13-0418. Epub 2013 Aug 29.

8.

Nutritional factors and preservation of C-peptide in youth with recently diagnosed type 1 diabetes: SEARCH Nutrition Ancillary Study.

Mayer-Davis EJ, Dabelea D, Crandell JL, Crume T, D'Agostino RB Jr, Dolan L, King IB, Lawrence JM, Norris JM, Pihoker C, The N.

Diabetes Care. 2013 Jul;36(7):1842-50. doi: 10.2337/dc12-2084.

9.

Exercise to preserve beta cell function in recent-onset type 1 diabetes mellitus (EXTOD)--a study protocol for a pilot randomized controlled trial.

Lascar N, Kennedy A, Jackson N, Daley A, Dowswell G, Thompson D, Stokes K, Greenfield S, Holder R, Andrews R, Narendran P.

Trials. 2013 Jun 18;14:180. doi: 10.1186/1745-6215-14-180.

10.

Lessons from the mixed-meal tolerance test: use of 90-minute and fasting C-peptide in pediatric diabetes.

Besser RE, Shields BM, Casas R, Hattersley AT, Ludvigsson J.

Diabetes Care. 2013 Feb;36(2):195-201. doi: 10.2337/dc12-0836. Epub 2012 Oct 30.

11.

Clinical evolution of beta cell function in youth with diabetes: the SEARCH for Diabetes in Youth study.

Dabelea D, Mayer-Davis EJ, Andrews JS, Dolan LM, Pihoker C, Hamman RF, Greenbaum C, Marcovina S, Fujimoto W, Linder B, Imperatore G, D'Agostino R Jr.

Diabetologia. 2012 Dec;55(12):3359-68. doi: 10.1007/s00125-012-2719-6. Epub 2012 Sep 20.

12.

Fall in C-peptide during first 2 years from diagnosis: evidence of at least two distinct phases from composite Type 1 Diabetes TrialNet data.

Greenbaum CJ, Beam CA, Boulware D, Gitelman SE, Gottlieb PA, Herold KC, Lachin JM, McGee P, Palmer JP, Pescovitz MD, Krause-Steinrauf H, Skyler JS, Sosenko JM; Type 1 Diabetes TrialNet Study Group..

Diabetes. 2012 Aug;61(8):2066-73. Epub 2012 Jun 11.

13.

The metabolic progression to type 1 diabetes as indicated by serial oral glucose tolerance testing in the Diabetes Prevention Trial-type 1.

Sosenko JM, Skyler JS, Herold KC, Palmer JP; Type 1 Diabetes TrialNet and Diabetes Prevention Trial–Type 1 Study Groups..

Diabetes. 2012 Jun;61(6):1331-7. doi: 10.2337/db11-1660. Review. No abstract available.

14.

Challenges in diagnosing type 1 diabetes in different populations.

Rewers M.

Diabetes Metab J. 2012 Apr;36(2):90-7. doi: 10.4093/dmj.2012.36.2.90. Epub 2012 Apr 17.

15.

Levels of C-peptide, body mass index and age, and their usefulness in classification of diabetes in relation to autoimmunity, in adults with newly diagnosed diabetes in Kronoberg, Sweden.

Thunander M, Törn C, Petersson C, Ossiansson B, Fornander J, Landin-Olsson M.

Eur J Endocrinol. 2012 Jun;166(6):1021-9. doi: 10.1530/EJE-11-0797. Epub 2012 Mar 21.

16.

Peripheral blood monocyte gene expression profile clinically stratifies patients with recent-onset type 1 diabetes.

Irvine KM, Gallego P, An X, Best SE, Thomas G, Wells C, Harris M, Cotterill A, Thomas R.

Diabetes. 2012 May;61(5):1281-90. doi: 10.2337/db11-1549. Epub 2012 Mar 8.

17.

Dead or alive?

Greenbaum CJ.

Diabetes Care. 2012 Mar;35(3):459-60. doi: 10.2337/dc11-2441. No abstract available.

18.

Antidiabetic actions of endogenous and exogenous GLP-1 in type 1 diabetic patients with and without residual β-cell function.

Kielgast U, Holst JJ, Madsbad S.

Diabetes. 2011 May;60(5):1599-607. doi: 10.2337/db10-1790. Epub 2011 Mar 25.

19.

German new onset diabetes in the young incident cohort study: DiMelli study design and first-year results.

Thümer L, Adler K, Bonifacio E, Hofmann F, Keller M, Milz C, Munte A, Ziegler AG.

Rev Diabet Stud. 2010 Fall;7(3):202-8. doi: 10.1900/RDS.2010.7.202. Epub 2010 Nov 10.

20.

Short-term hyperglycemia increases arterial superoxide production and iron dysregulation in atherosclerotic monkeys.

Rowe PA, Kavanagh K, Zhang L, Harwood HJ Jr, Wagner JD.

Metabolism. 2011 Aug;60(8):1070-80. doi: 10.1016/j.metabol.2010.11.003. Epub 2011 Jan 19.

Supplemental Content

Support Center